Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Contact Expert
View Scopus Profile
Li Wang, PhD
Associate Professor
,
Department of Public Health Sciences
Division of Health Services and Behavioral Research
Penn State Cancer Institute
Cancer Institute, Cancer Control
h-index
1034
Citations
16
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1993 …
2025
Research activity per year
Overview
Fingerprint
Network
Grants & Projects
(1)
Research output
(45)
Prizes
(1)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Li Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cost-effectiveness
81%
Non-Hispanic White
64%
US Adults
60%
National Health Interview Survey
57%
NHANES
57%
Cancer Patients
43%
Race-ethnicity
41%
Parametric Conditional Distribution
38%
Integrated Conditional Moment Test
38%
Alzheimer's Dementia
38%
Racial Disparities
38%
Cost-effectiveness Analysis
38%
Related Dementia
38%
Health Care Costs
36%
Blood Lead Level
35%
Autism Spectrum Disorder
33%
Behavioral Risk Factor Surveillance System (BRFSS)
26%
African American
25%
Odds Ratio
25%
Outcome Costs
24%
Health Outcomes
23%
Autism
23%
Teaching Hospital
23%
United States
22%
Private Health Insurance
22%
Surveillance Epidemiology
22%
Lead Exposure
21%
End-of-life Care
21%
Associated Costs
21%
Clinical Outcomes
21%
Hospital Costs
21%
Length of Stay
21%
Colorectal Cancer
21%
Vaccination
20%
Specific Types
20%
Cancer Disease
20%
White Patients
19%
COVID-19 Transmission
19%
Fluticasone Propionate
19%
Tumor Size
19%
Operational Scenario
19%
Dynamic Gene Expression
19%
Cardiovascular Mortality
19%
In Cancer
19%
Gaps in Care
19%
Health-related Quality of Life
19%
Non-adherence
19%
Intensive Care Unit
19%
Social Support
19%
US Surveillance
19%
Medicine and Dentistry
Health Care Cost
100%
Malignant Neoplasm
80%
Surveillance, Epidemiology, and End Results
42%
Cancer Survival
38%
Cost-Effectiveness Analysis
38%
Alzheimer's Disease
38%
Diabetes
31%
Primary Health Care
31%
Neoplasm
28%
Marital Status
25%
Pediatrics
25%
Breast Cancer
24%
End of Life Care
21%
Linear Regression Analysis
20%
Quality of Life
20%
Zanubrutinib
19%
COVID-19
19%
Colon Carcinoma
19%
Patient with Alzheimer's Disease
19%
Awareness
19%
Intensive Care Unit
19%
Mass Casualty
19%
Disease
19%
Health Care
19%
Lead Poisoning
19%
Dysglycemia
19%
Ibrutinib
19%
B-Cell Chronic Lymphocytic Leukemia
19%
Thyroid Cancer
19%
Chronic Kidney Disease
19%
Bariatric Surgery
19%
Influenza Vaccine
19%
Well Child Care
19%
Glycemic
19%
Scapula
19%
Oncology
19%
Ethnic Disparity
19%
Healthy Eating
19%
Surgeon
19%
Colon Cancer
19%
Medical Care
19%
Pervasive Developmental Disorder
19%
Kidney Allograft
19%
Hepatitis B Vaccine
19%
Hepatitis B Vaccination
15%
Chi Square Test
14%
Logistic Regression Analysis
13%
Computer Assisted Tomography
13%
Cancer Staging
13%
